Arbutus Biopharma Corpora... (ABUS)
NASDAQ: ABUS
· Real-Time Price · USD
3.33
-0.04 (-1.19%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.01%
After-hours: Aug 15, 2025, 05:47 PM EDT
Arbutus Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -15.77M | -21.32M | -19.16M | -19.39M | -16.38M |
Depreciation & Amortization | 11K | 330K | 333K | 336K | 356K | 355K | 359K | 369K | 342K | 334K | 307K | 343K | 383K | 394K | 427K | 447K | 436K | 443K |
Stock-Based Compensation | 864K | 3.56M | 1.63M | 2.16M | 3.18M | 2.01M | 1.72M | 2.48M | 2.96M | 2.13M | 1.67M | 1.72M | 2.06M | 1.74M | 1.43M | 1.61M | 1.74M | 1.64M |
Other Working Capital | n/a | -503K | 572K | 900.08K | -468.3K | -472K | 789.37K | -3.83M | -3.02M | -4.65M | -729K | -1.33M | -10.72M | 37.26M | 242K | 1.42M | 2.63M | -973K |
Other Non-Cash Items | -19.15M | 1.97M | 481K | -1.02M | -98.54K | 4.18M | 764.86K | -472K | -1.23M | -1.09M | -546K | -1.78M | -935K | -488K | -1.39M | -243K | 310K | -59K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.5M | -678K | -534K | n/a | n/a | n/a | n/a | n/a | 241K | 256K | 294K | 203K |
Change in Working Capital | n/a | 5.27M | -229K | -2.5M | 2.76M | -2.86M | 1.73M | -3.38M | -4M | -12.33M | 3.51M | -1.4M | -7.61M | 34.74M | 1.01M | 1.05M | 2.6M | -3.72M |
Operating Cash Flow | -15.75M | -13.39M | -10.31M | -20.74M | -14.26M | -19.3M | -16.23M | -21.78M | -19.56M | -27.3M | -16.99M | -18.69M | -20.29M | 20.62M | -19.61M | -16.04M | -14.01M | -17.88M |
Capital Expenditures | n/a | n/a | -86K | n/a | -320.63 | -95K | 13.36K | -32K | -859K | -117K | -134K | -91K | -212K | -75K | -58K | -20K | -632K | -99K |
Cash Acquisitions | n/a | n/a | n/a | -37.19M | n/a | 37.19M | -265.1 | 20.08K | -2.3M | -268K | -19.64K | -273.61 | 19.92K | -1.76M | 1.81M | n/a | n/a | -20.09M |
Purchase of Investments | 14.93M | 10.63M | -43.19M | 64.99M | -32.17M | -25.4M | -23.05M | -7.08M | -29.2M | -20.2M | -13.16M | -32.65M | -22.64M | -61.98M | -28.06M | -11K | -52.12M | -2.03M |
Sales Maturities Of Investments | n/a | n/a | 56.69M | -79.04M | 41.85M | 37.19M | 44.69M | 17.53M | 31.5M | 37M | 26M | 19M | 9M | 2M | 20M | 16M | 14M | 20.35M |
Other Investing Acitivies | 677K | 718K | -3.33K | 39.25M | 9.73M | 458K | 1.10 | -84 | 2.3M | 268K | -355 | 273.61 | 81.00 | 1.76M | -1.81M | 15.99M | -38.12M | 20.09M |
Investing Cash Flow | 15.61M | 11.35M | 13.41M | -11.99M | 9.68M | 11.69M | 21.65M | 10.43M | 1.44M | 16.68M | 12.68M | -13.74M | -13.83M | -60.06M | -8.12M | 15.97M | -38.75M | 18.22M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.14M | n/a | n/a | -3.21M |
Other Financial Acitivies | 453K | 2.78M | 1.42M | 1.77M | 345.35K | 2.67M | -45K | 285K | n/a | 555K | 1K | 159K | 113K | 11.22M | 12.02M | 2.22M | 15K | 3.67M |
Financial Cash Flow | 453K | 2.78M | 1.42M | 1.77M | 24.02M | 24.43M | 3.42M | 1.68M | 4.74M | 20.42M | 11.08M | 9.13M | 113K | 11.48M | 59.12M | 46.95M | 4.29M | 26.87M |
Net Cash Flow | 336K | 746K | 4.48M | -30.94M | 19.69M | 16.82M | 8.75M | -9.67M | -13.38M | 9.8M | 6.77M | -23.32M | -34.01M | -27.95M | 31.4M | 46.93M | -48.47M | 27.17M |
Free Cash Flow | -15.75M | -13.39M | -10.4M | -20.74M | -14.27M | -19.39M | -16.21M | -21.82M | -20.42M | -27.42M | -17.12M | -18.78M | -20.5M | 20.54M | -19.66M | -16.06M | -14.64M | -17.98M |